Antioxidants in Cardiovascular Diseases
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Health Outcomes of Antioxidants and Oxidative Stress".
Deadline for manuscript submissions: 25 June 2024 | Viewed by 310
Special Issue Editors
Interests: cardiovascular disease; vascular biology; therapeutic target; nutritional intervention; nutraceuticals; cell metabolism; mitochondria
Special Issues, Collections and Topics in MDPI journals
Interests: cardiovascular disease; metabolic diseases; mitochondrial metabolism; mtDNA mutation/editing; ROS
Special Issues, Collections and Topics in MDPI journals
Interests: iron metabolism; oxidative stress; intervention strategies
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases (CVDs) are the leading cause of death globally. Imbalanced oxidative stress acts as a key determinant driving the pathogenesis and progression of multiple CVDs and is therefore an emerging therapeutic target. Despite the great achievements in this field, limitations such as the low therapeutic efficacy of antioxidants in a certain type of CVD, poor pharmaceutical properties, lack of site-specific delivery, and unclear mechanisms of action remain to be addressed.
This Special Issue is aimed at providing selected contributions on advances in the identification and development of new forms of antioxidants, their mechanisms, and potential applications in cardiovascular biology and disease management. Potential topics include, but are not limited to the following: novel antioxidant agents for CVDs; mechanisms of action of a specific antioxidant in CVDs; future perspectives for antioxidants in CVDs; development of new nanoformulations of antioxidants; adverse effects of nanoformulations of antioxidants; biopharmaceutical or pharmacokinetics of nanoformulations for CVDs.
Dr. Yongting Luo
Dr. Junjie Luo
Dr. Peng An
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardiovascular disease
- antioxidants
- ROS
- mechanism
- nanoformulations
